Skip to main content
Top
Published in: BMC Clinical Pathology 1/2014

Open Access 01-12-2014 | Research article

Ultrastructural features of neuroblastic tumours in relation to morphological, and molecular findings; a retrospective review study

Authors: Elizabeth Latimer, Glenn Anderson, Neil James Sebire

Published in: BMC Clinical Pathology | Issue 1/2014

Login to get access

Abstract

Background

Neuroblastoma is the most common solid tumour of infancy and is responsible for 15% of childhood cancer deaths. Presence of amplified MYCN in neuroblastoma is associated with poor prognosis and rapid tumour progression. The aim of this study was to examine and compare the ultrastructural features of high-risk MYCN amplified neuroblastomas, with lower-risk non-MYCN amplified tumours.

Methods

This was a retrospective study evaluating archival diagnostic tissue samples, in which Fluorescence in-situ hybridisation (FISH) had been used at diagnosis to establish MYCN status. 22 (11 MYCN amplified tumours and 11 non-MYCN amplified) tumours of similar light microscopic appearance (poorly differentiated neuroblastoma) were then selected for ultrastructural examination.

Results

There is a relationship between ultrastructural features in neuroblastoma and MYCN status, although with marked overlap between groups. MYCN amplified tumours generally exhibited a ‘less differentiated’ ultrastructural phenotype, with significantly smaller neurotubules (NT) in the cell body (p < 0.002). Non-MYCN amplified tumours show increased features of neuronal differentiation, with fewer neurosecretory granules (NSG) and NT in the cytoplasm.

Conclusions

MYCN amplification is associated with a less differentiated ultrastructural phenotype, and lack of MYCN amplification with relative ultrastructural neuronal differentiation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schwab M, Westermann F, Hero B, Berthold F: Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol. 2003, 4: 472-480. 10.1016/S1470-2045(03)01166-5.CrossRefPubMed Schwab M, Westermann F, Hero B, Berthold F: Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol. 2003, 4: 472-480. 10.1016/S1470-2045(03)01166-5.CrossRefPubMed
2.
go back to reference Park JR, Eggert A, Caron H: Neuroblastoma: biology, prognosis, and treatment. Hematol/Oncol Clin N Am. 2010, 24: 65-86. 10.1016/j.hoc.2009.11.011.CrossRef Park JR, Eggert A, Caron H: Neuroblastoma: biology, prognosis, and treatment. Hematol/Oncol Clin N Am. 2010, 24: 65-86. 10.1016/j.hoc.2009.11.011.CrossRef
3.
go back to reference Weinstein JL, Katzenstein HM, Cohn SL: Advances in the diagnosis and treatment of neuroblastoma. Oncologist. 2003, 8: 278-292. 10.1634/theoncologist.8-3-278.CrossRefPubMed Weinstein JL, Katzenstein HM, Cohn SL: Advances in the diagnosis and treatment of neuroblastoma. Oncologist. 2003, 8: 278-292. 10.1634/theoncologist.8-3-278.CrossRefPubMed
4.
go back to reference Sebire NJ, Malone M, Ashworth M, Jacques TS: Tumours. Chapter 6. Diagnostic Pediatric Surgical Pathology. 2010, London: Churchill Livingstone, 165-172. Sebire NJ, Malone M, Ashworth M, Jacques TS: Tumours. Chapter 6. Diagnostic Pediatric Surgical Pathology. 2010, London: Churchill Livingstone, 165-172.
5.
go back to reference Mueller S, Matthay KK: Neuroblastoma: biology and staging. Curr Oncol Rep. 2009, 11: 431-438. 10.1007/s11912-009-0059-6.CrossRefPubMed Mueller S, Matthay KK: Neuroblastoma: biology and staging. Curr Oncol Rep. 2009, 11: 431-438. 10.1007/s11912-009-0059-6.CrossRefPubMed
6.
go back to reference Westermark UK, Wilhelm M, Frenzel A, Henriksson MA: The MYCN oncogene and differentiation in neuroblastoma. Semin Canc Biol. 2011, 21: 256-266. 10.1016/j.semcancer.2011.08.001.CrossRef Westermark UK, Wilhelm M, Frenzel A, Henriksson MA: The MYCN oncogene and differentiation in neuroblastoma. Semin Canc Biol. 2011, 21: 256-266. 10.1016/j.semcancer.2011.08.001.CrossRef
7.
go back to reference Zimmerman KA, Yancopoulos GD, Collum RG, Smith RK, Kohl NE, Denis KA, Nau MM, Witte ON, Toran-Allerand D, Gee CE, Minna JD, Alt FW: Differential expression of myc family genes during murine development. Nature. 1986, 319: 780-783. 10.1038/319780a0.CrossRefPubMed Zimmerman KA, Yancopoulos GD, Collum RG, Smith RK, Kohl NE, Denis KA, Nau MM, Witte ON, Toran-Allerand D, Gee CE, Minna JD, Alt FW: Differential expression of myc family genes during murine development. Nature. 1986, 319: 780-783. 10.1038/319780a0.CrossRefPubMed
8.
go back to reference Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, Cheung NK, Seeger RC, Evans AE, Ikegaki N: The MYCN enigma: significance of MYCN expression in neuroblastoma. Canc Res. 2006, 66: 2826-2833. 10.1158/0008-5472.CAN-05-0854.CrossRef Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, Cheung NK, Seeger RC, Evans AE, Ikegaki N: The MYCN enigma: significance of MYCN expression in neuroblastoma. Canc Res. 2006, 66: 2826-2833. 10.1158/0008-5472.CAN-05-0854.CrossRef
9.
go back to reference Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Fukuba I, Matsuura Y, Yokoyama T: Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1. Med Pediat Oncol. 2001, 6: 67-74.CrossRef Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Fukuba I, Matsuura Y, Yokoyama T: Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1. Med Pediat Oncol. 2001, 6: 67-74.CrossRef
10.
go back to reference Yanagisawa M: Electron microscopic study of neuroblastoma. Paediatr Univ Tokyo. 1970, 17: 29-39.PubMed Yanagisawa M: Electron microscopic study of neuroblastoma. Paediatr Univ Tokyo. 1970, 17: 29-39.PubMed
11.
go back to reference Romansky SG, Crocker DW, Shaw KN: Ultrastructural studies on neuroblastoma: evaluation of cytodifferentiation and correlation of morphology and biochemical and survival data. Cancer. 1978, 42: 2392-2398. 10.1002/1097-0142(197811)42:5<2392::AID-CNCR2820420540>3.0.CO;2-C.CrossRefPubMed Romansky SG, Crocker DW, Shaw KN: Ultrastructural studies on neuroblastoma: evaluation of cytodifferentiation and correlation of morphology and biochemical and survival data. Cancer. 1978, 42: 2392-2398. 10.1002/1097-0142(197811)42:5<2392::AID-CNCR2820420540>3.0.CO;2-C.CrossRefPubMed
12.
go back to reference Taxy JB: Electron microscopy in the diagnosis of neuroblastoma. Arch Pathol Lab Med. 1980, 104: 355-360.PubMed Taxy JB: Electron microscopy in the diagnosis of neuroblastoma. Arch Pathol Lab Med. 1980, 104: 355-360.PubMed
13.
go back to reference Shimada H: Transmission and scanning electron microscopic studies on the tumors of neuroblastoma group. Acta Pathol Jpn. 1982, 32: 415-426.PubMed Shimada H: Transmission and scanning electron microscopic studies on the tumors of neuroblastoma group. Acta Pathol Jpn. 1982, 32: 415-426.PubMed
14.
go back to reference Hicks MJ, Mackay B: Comparison of ultrastructural features among neuroblastic tumors: maturation from neuroblastoma to ganglioneuroma. Ultrastruct Pathol. 1995, 19: 311-322. 10.3109/01913129509064236.CrossRefPubMed Hicks MJ, Mackay B: Comparison of ultrastructural features among neuroblastic tumors: maturation from neuroblastoma to ganglioneuroma. Ultrastruct Pathol. 1995, 19: 311-322. 10.3109/01913129509064236.CrossRefPubMed
15.
go back to reference Bancroft JD, Gamble M: Theory and Practice of Histological Techniques. 2008, London: Churchill Livingstone, 126-127. Sixth Bancroft JD, Gamble M: Theory and Practice of Histological Techniques. 2008, London: Churchill Livingstone, 126-127. Sixth
16.
go back to reference Taylor CP, Bown NP, McGuckin AG, Lunec J, Malcolm AJ, Pearson AD, Sheer D: Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma. United Kingdom Children’s Cancer Study Group. Br J Canc. 2000, 83: 40-49.CrossRef Taylor CP, Bown NP, McGuckin AG, Lunec J, Malcolm AJ, Pearson AD, Sheer D: Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma. United Kingdom Children’s Cancer Study Group. Br J Canc. 2000, 83: 40-49.CrossRef
17.
go back to reference Lundberg G, Rosengren AH, Håkanson U, Stewénius H, Jin Y, Stewénius Y, Påhlman S, Gisselsson D: Binomial mitotic segregation of MYCN-carrying double minutes in neuroblastoma illustrates the role of randomness in oncogene amplification. PLoS One. 2008, 3: e3099-10.1371/journal.pone.0003099.CrossRefPubMedPubMedCentral Lundberg G, Rosengren AH, Håkanson U, Stewénius H, Jin Y, Stewénius Y, Påhlman S, Gisselsson D: Binomial mitotic segregation of MYCN-carrying double minutes in neuroblastoma illustrates the role of randomness in oncogene amplification. PLoS One. 2008, 3: e3099-10.1371/journal.pone.0003099.CrossRefPubMedPubMedCentral
18.
go back to reference Erlandson RA: Diagnostic Transmission electron Microscopy of Tumors. 1994, New York: Raven Press, 555-562. Erlandson RA: Diagnostic Transmission electron Microscopy of Tumors. 1994, New York: Raven Press, 555-562.
20.
go back to reference Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF: Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev. 1992, 6: 2235-2247. 10.1101/gad.6.12a.2235.CrossRefPubMed Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF: Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev. 1992, 6: 2235-2247. 10.1101/gad.6.12a.2235.CrossRefPubMed
21.
go back to reference Wakamatsu Y, Watanabe Y, Nakamura H, Kondoh H: Regulation of the neural crest cell fate by N-myc: promotion of ventral migration and neuronal differentiation. Development. 1997, 197 (124): 1953-1962. Wakamatsu Y, Watanabe Y, Nakamura H, Kondoh H: Regulation of the neural crest cell fate by N-myc: promotion of ventral migration and neuronal differentiation. Development. 1997, 197 (124): 1953-1962.
22.
go back to reference Alam G, Cui H, Shi H, Yang L, Ding J, Mao L, Maltese WA, Ding HF: MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development. Am J Pathol. 2009, 175: 856-866. 10.2353/ajpath.2009.090019.CrossRefPubMedPubMedCentral Alam G, Cui H, Shi H, Yang L, Ding J, Mao L, Maltese WA, Ding HF: MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development. Am J Pathol. 2009, 175: 856-866. 10.2353/ajpath.2009.090019.CrossRefPubMedPubMedCentral
23.
go back to reference Gustafson WC, Matthay KK: Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma. Exp Rev Neurotherapeutics. 2011, 11: 1411-1423. 10.1586/ern.11.103.CrossRef Gustafson WC, Matthay KK: Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma. Exp Rev Neurotherapeutics. 2011, 11: 1411-1423. 10.1586/ern.11.103.CrossRef
Metadata
Title
Ultrastructural features of neuroblastic tumours in relation to morphological, and molecular findings; a retrospective review study
Authors
Elizabeth Latimer
Glenn Anderson
Neil James Sebire
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Clinical Pathology / Issue 1/2014
Electronic ISSN: 1472-6890
DOI
https://doi.org/10.1186/1472-6890-14-13

Other articles of this Issue 1/2014

BMC Clinical Pathology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.